Pharmacokinetics of the individual enantiomers of vigabatrin (gamma-vinyl GABA) in epileptic children.
about
Vigabatrin.The clinical pharmacokinetics of the new antiepileptic drugs.Vigabatrin: a novel therapy for seizure disorders.Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age: an update.Passage of S(+) and R(-) gamma-vinyl-GABA across the human isolated perfused placenta.Monitoring vigabatrin in head injury patients by cerebral microdialysis: obtaining pharmacokinetic measurements in a neurocritical care setting.Chiral chromatographic resolution of antiepileptic drugs and their metabolites: a challenge from the optimization to the application.Modern methods for analysis of antiepileptic drugs in the biological fluids for pharmacokinetics, bioequivalence and therapeutic drug monitoring.Mirror images: the analysis of pharmaceutical enantiomers.Vigabatrin: placental transfer in vivo and excretion into breast milk of the enantiomers.Pharmacology of vigabatrin.Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age.Drug disposition in three dimensions: an update on stereoselectivity in pharmacokinetics.Reduced grating acuity associated with retinal toxicity in children with infantile spasms on vigabatrin therapy.Vigabatrin: a comprehensive review of drug properties including clinical updates following recent FDA approval.Vigabatrin for infantile spasms.Mechanism of action of vigabatrin: correcting misperceptions.A systematic review of the pharmacokinetics of antiepileptic drugs in neonates with refractory seizures.Pharmacokinetic aspects of the anti-epileptic drug substance vigabatrin: focus on transporter interactions.Population pharmacokinetics analysis of vigabatrin in adults and children with epilepsy and children with infantile spasms.Pharmacokinetic interaction studies between felbamate and vigabatrin.Pharmacological and behavioral characteristics of interactions between vigabatrin and conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: an isobolographic analysis.
P2860
Q33756754-5DF1722E-1342-46BB-9D99-22C27A05886DQ33804499-74B1F640-36D8-4C62-9455-80ADF02B3F6BQ33814543-EDED9FA7-76CA-44EA-8D7F-2363E510DE6EQ34342674-091300C2-5DAD-42FC-9AA1-4726AEAD4356Q34403607-DBDCF730-855D-4CA7-AB57-8971190AA677Q34570859-E36F1E7D-EC2B-47D1-B4A5-1F64D3CC02A9Q34941977-C52D57B5-A148-4782-A6CD-7A9786CB574DQ35014028-0B314FA7-A269-4A18-942C-E351EC882BD8Q35536298-38271712-CC35-434D-8415-222C53003BFAQ35802976-14151403-9849-4E3A-A8D8-EED191652066Q36223272-888D3F50-6246-4150-90F5-C51A1498E5CBQ36439208-9B42B71F-1DCC-4AD1-BA8F-BEC5DC51D8FDQ36582463-CEB3A494-7653-47D1-A9E4-CB2B839E0293Q37431696-02130022-CADF-4171-8CCE-5B8009177DF4Q37642768-37CAB96B-4A2A-49CE-864F-ADE200E1DDB2Q37848404-3F9E683E-F59A-4064-A5D8-55FAAE48E9D1Q37953574-BF9273A3-F586-45FD-920B-4B7120A1F093Q38057226-471AB018-752A-416C-AF5D-C7C7A0244AE3Q38261962-501A9C5F-6566-4BB1-A5CD-EB70B12EE333Q42679724-178CA013-8E46-43FA-8AB9-0623F79B758FQ43201999-37082D0E-31CB-444E-9E33-21973E84BA76Q45138847-E927FCF9-E756-4A1B-B657-437FBDB5301A
P2860
Pharmacokinetics of the individual enantiomers of vigabatrin (gamma-vinyl GABA) in epileptic children.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Pharmacokinetics of the indivi ...... l GABA) in epileptic children.
@en
Pharmacokinetics of the individual enantiomers of vigabatrin
@nl
type
label
Pharmacokinetics of the indivi ...... l GABA) in epileptic children.
@en
Pharmacokinetics of the individual enantiomers of vigabatrin
@nl
prefLabel
Pharmacokinetics of the indivi ...... l GABA) in epileptic children.
@en
Pharmacokinetics of the individual enantiomers of vigabatrin
@nl
P2093
P2860
P1476
Pharmacokinetics of the indivi ...... l GABA) in epileptic children.
@en
P2093
Beaumont D
Richard MO
Vauzelle F
P2860
P304
P356
10.1111/J.1365-2125.1990.TB03772.X
P407
P577
1990-08-01T00:00:00Z